Orthofix Medical (NASDAQ:OFIX) Rating Reiterated by JMP Securities

Orthofix Medical (NASDAQ:OFIX)‘s stock had its “market perform” rating reiterated by analysts at JMP Securities in a research report issued on Monday, Benzinga reports.

Other research analysts have also recently issued reports about the stock. StockNews.com cut shares of Orthofix Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, March 6th. Roth Mkm upped their price objective on shares of Orthofix Medical from $12.00 to $15.00 and gave the stock a “neutral” rating in a research report on Thursday, March 7th. One research analyst has rated the stock with a sell rating and four have issued a hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $15.50.

Orthofix Medical Trading Up 1.1 %

Shares of OFIX opened at $13.22 on Monday. The business’s 50-day moving average price is $13.72 and its 200-day moving average price is $12.91. Orthofix Medical has a twelve month low of $9.57 and a twelve month high of $21.60. The stock has a market cap of $494.56 million, a PE ratio of -3.19 and a beta of 1.04. The company has a quick ratio of 1.20, a current ratio of 2.54 and a debt-to-equity ratio of 0.19.

Orthofix Medical (NASDAQ:OFIX) last announced its quarterly earnings results on Tuesday, March 5th. The medical device company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.60) by $0.01. The firm had revenue of $200.42 million for the quarter. Orthofix Medical had a negative return on equity of 10.63% and a negative net margin of 20.28%. On average, equities analysts forecast that Orthofix Medical will post -1.51 EPS for the current fiscal year.

Institutional Trading of Orthofix Medical

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Rubric Capital Management LP boosted its stake in Orthofix Medical by 6.7% in the fourth quarter. Rubric Capital Management LP now owns 3,665,000 shares of the medical device company’s stock worth $49,404,000 after buying an additional 230,335 shares in the last quarter. Armistice Capital LLC boosted its stake in Orthofix Medical by 21.5% in the fourth quarter. Armistice Capital LLC now owns 3,600,000 shares of the medical device company’s stock worth $48,528,000 after buying an additional 636,000 shares in the last quarter. Engine Capital Management LP purchased a new stake in Orthofix Medical in the fourth quarter worth approximately $40,916,000. Vanguard Group Inc. boosted its stake in Orthofix Medical by 3.3% in the third quarter. Vanguard Group Inc. now owns 2,486,073 shares of the medical device company’s stock worth $31,971,000 after buying an additional 79,793 shares in the last quarter. Finally, AWM Investment Company Inc. boosted its stake in Orthofix Medical by 77.4% in the third quarter. AWM Investment Company Inc. now owns 598,463 shares of the medical device company’s stock worth $7,696,000 after buying an additional 261,081 shares in the last quarter. Hedge funds and other institutional investors own 89.76% of the company’s stock.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.